Fund Holdings — Propel Bio Management, LLC

Total Portfolio Value:
$100.69M
Total Bought:
$56.07M
Total Sold:
$8.28M
Net Transaction:
+$47.78M
Notable People:
Leen Kawas, James Francis Harding
Securities
▲▼
SharesValue
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Plains GP Holdings, L.P.COMM(PAGP)1,272,3601,272,3600$23.54M$23.39M23.23%-$152.7K
Madrigal Pharmaceuticals, Inc.COMM(MDGL)43,03243,0320$9.13M$13.28M13.19%+$4.15M
Akero Therapeutics IncCOMM343,729343,7290$9.86M$9.56M9.50%-$299.0K
Achieve Life Sciences IncCOMM2,453,0922,453,0920$11.63M$8.63M8.58%-$2.99M
Applied Therapeutics IncCOMM6,567,8589,615,420+3,047,562$55.83M$8.23M8.18%-$47.59M
Phathom Pharmaceuticals, Inc.COMM(PHAT)869,927989,927+120,000$15.73M$8.04M7.98%-$7.69M
TScan Therapeutics, Inc.COMM(TCRX)2,087,1392,087,1390$10.39M$6.34M6.30%-$4.05M
Avidity Biosciences IncCOMM178,500178,5000$8.20M$5.19M5.16%-$3.01M
Ardelyx IncCOMM1,070,947950,947-120,000$7.38M$4.82M4.79%-$2.56M
Abeona Therapeutics Inc.COMM(ABEO)624,022624,0220$3.94M$3.48M3.45%-$468.0K
Syndax Pharmaceuticals, Inc.COMM(SNDX)133,259183,259+50,000$2.57M$2.42M2.41%-$142.6K
Kymera Therapeutics, Inc.COMM(KYMR)56,35956,3590$2.67M$2.27M2.25%-$400.1K
Zevra Therapeutics, Inc.COMM(ZVRA)179,874179,8740$1.25M$1.50M1.49%+$251.8K
Kura Oncology, Inc.COMM(KURA)130,000130,0000$2.54M$1.13M1.12%-$1.41M
Athira Pharma IncCOMM1,492,7921,492,7920$665.8K$875.8K0.87%+$210.0K
Eiger BiopharmaceuticalsCOMM146,381146,3810$1.24M$765.0K0.76%-$479.2K
Jasper Therapeutics, Inc.COMM(JSPR)020,000+20,000$0$427.6K0.42%+$427.6K
Delcath Systems, Inc.COMM(DCTH)017,000+17,000$0$204.7K0.20%+$204.7K
COMPASS Pathways plcCOMM(CMPS)80,00025,209-54,791$504.0K$95.3K0.09%-$408.7K
Maat Pharma SacaCOMM2,3973,151+754$17.8K$25.1K0.02%+$7.3K
Chinook TherapeuticsCOMM79,35779,3570$9.8K$9.8K0.01%$0
Verrica Pharmaceuticals Inc.COMM(VRCA)344,9370-344,937$500.2K$0—-$500.2K
Telesat CorporationCOMM(TSAT)365,7810-365,781$4.82M$0—-$4.82M
Page 1 of 1